Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-03

Clinical Trial Update: A Study of the Safety of IMOVAX Polio™ in China [Phase 4]

View source ↗

Summary

A Phase 4 safety study of IMOVAX Polio conducted in China has completed. The trial was sponsored by Sanofi.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IMOVAX Polio (inactivated poliovirus vaccine)

Snippet

Sponsor: Sanofi | Conditions: Poliomyelitis, Polio | Phase 4 | Status: COMPLETED